• Policy
• Govn’t to prepurchase 10 mil of SK Bio’s COVID-19 vaccine
• by Kim, Jung-Ju Dec 24, 2021 05:49am

• InterView
• Ibrance can be used regardless of underlying condition in BC
• by Dec 24, 2021 05:48am

• Policy
• Domestic approval of EU-approved Novavax is imminent
• by Lee, Tak-Sun Dec 24, 2021 05:48am

• Company
• GI Innovation·A/Z, a study on immuno-cancer drugs combined
• by Nho, Byung Chul Dec 24, 2021 05:48am

• Policy
• The PV guideline amendments may not be applied on Jan. 1st
• by Lee, Hye-Kyung Dec 23, 2021 05:42am

• Company
• MSD's Delstrigo can be prescribed in general hospitals
• by Eo, Yun-Ho Dec 23, 2021 05:42am

• Company
• [2021 Pharmaceutical Patent Settlement] The target is Dukarb
• by Kim, Jin-Gu Dec 23, 2021 05:41am

• Company
• MNC employees enjoy 17 days maximum as year-end holidays
• by Eo, Yun-Ho Dec 22, 2021 05:57am

• Policy
• Kyprolis succeeded in renewing the RSA contract
• by Kim, Jung-Ju Dec 22, 2021 05:56am

• Company
• JW Pharm to discuss technical partnerships for its gout Tx
• by Lee, Seok-Jun Dec 22, 2021 05:56am